Detalles de la búsqueda
1.
Phase 2 prospective open label study of neoadjuvant nab-paclitaxel, trastuzumab, and pertuzumab in patients with HER2-positive primary breast cancer.
Cancer
; 129(5): 740-749, 2023 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36517940
2.
Phase I Trial of Ipatasertib Plus Carboplatin, Carboplatin/Paclitaxel, or Capecitabine and Atezolizumab in Metastatic Triple-Negative Breast Cancer.
Oncologist
; 28(7): e498-e507, 2023 07 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37023705
3.
Immunogenicity and efficacy of pembrolizumab and doxorubicin in a phase I trial for patients with metastatic triple-negative breast cancer.
Cancer Immunol Immunother
; 72(9): 3013-3027, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37294342
4.
Safety and Efficacy of Oxaliplatin Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC) in Colorectal and Appendiceal Cancer with Peritoneal Metastases: Results of a Multicenter Phase I Trial in the USA.
Ann Surg Oncol
; 30(12): 7814-7824, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37501051
5.
Phase II Trial of Neoadjuvant Carboplatin and Nab-Paclitaxel in Patients with Triple-Negative Breast Cancer.
Oncologist
; 26(3): e382-e393, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33098195
6.
A Phase II Clinical Trial of Pembrolizumab and Enobosarm in Patients with Androgen Receptor-Positive Metastatic Triple-Negative Breast Cancer.
Oncologist
; 26(2): 99-e217, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33141975
7.
A Pilot Study of Vinorelbine Safety and Pharmacokinetics in Patients with Varying Degrees of Liver Dysfunction.
Oncologist
; 24(8): 1137-1145, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-30710067
8.
NCI 8628: A randomized phase 2 study of ziv-aflibercept and high-dose interleukin 2 or high-dose interleukin 2 alone for inoperable stage III or IV melanoma.
Cancer
; 124(22): 4332-4341, 2018 11 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-30303516
9.
ASO Visual Abstract: Safety and Efficacy of Oxaliplatin Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC) in Colorectal and Appendiceal Cancer with Peritoneal Metastases: Results of a Multicenter Phase I Trial in the United States.
Ann Surg Oncol
; 30(12): 7869-7870, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37598124
10.
A phase I trial of mushroom powder in patients with biochemically recurrent prostate cancer: Roles of cytokines and myeloid-derived suppressor cells for Agaricus bisporus-induced prostate-specific antigen responses.
Cancer
; 121(17): 2942-50, 2015 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-25989179
11.
Pazopanib as third line therapy for metastatic renal cell carcinoma: clinical efficacy and temporal analysis of cytokine profile.
J Urol
; 193(4): 1114-21, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25286010
12.
Sequential bortezomib, dexamethasone, and thalidomide maintenance therapy after single autologous peripheral stem cell transplantation in patients with multiple myeloma.
Biol Blood Marrow Transplant
; 18(3): 486-92, 2012 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-22198542
13.
Long-Term Outcomes of Patients on a Phase II Prospective Trial of Oligometastatic Hormone-Sensitive Prostate Cancer Treated With Androgen Deprivation and External Beam Radiation.
Int J Radiat Oncol Biol Phys
; 114(4): 705-710, 2022 11 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-35803445
14.
Oligometastatic Breast Cancer Patients Treated with High-Dose Chemotherapy and Targeted Radiation: Long-Term Follow-Up of a Phase II Trial.
Cancers (Basel)
; 14(20)2022 Oct 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-36291784
15.
Phase II Study Combining Pembrolizumab with Aromatase Inhibitor in Patients with Metastatic Hormone Receptor Positive Breast Cancer.
Cancers (Basel)
; 14(17)2022 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36077811
16.
Phase I/II trial of palbociclib, pembrolizumab and letrozole in patients with hormone receptor-positive metastatic breast cancer.
Eur J Cancer
; 154: 11-20, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34217908
17.
Human papillomavirus infection as a prognostic factor in oropharyngeal squamous cell carcinomas treated in a prospective phase II clinical trial.
Anticancer Res
; 29(5): 1467-74, 2009 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-19443352
18.
Assessment of low prostate weight as a determinant of a higher positive margin rate after laparoscopic radical prostatectomy: a prospective pathologic study of 1,500 cases.
Surg Endosc
; 23(5): 1058-64, 2009 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-18813992
19.
Randomized trial of oral cyclophosphamide versus oral cyclophosphamide with celecoxib for recurrent epithelial ovarian, fallopian tube, and primary peritoneal cancer.
Cancer Treat Res Commun
; 21: 100155, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31279962
20.
Resident memory CD8+ T cells within cancer islands mediate survival in breast cancer patients.
JCI Insight
; 4(19)2019 10 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31465302